Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Covance Inc.    CVD   US2228161004

COVANCE INC. (CVD)

23
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Latest news on COVANCE INC.
04/08 COVANCE : Big Data Experts from Covance, Gilead and Johnson-Johnson to Keynote a..
04/03 COVANCE : Invites You to Join the Webcast of Its First Quarter 2014 Financial Re..
03/25 COVANCE : expands Global Biologics Capabilities
03/12 COVANCE : To Present At The Raymond James 35th Annual Institutional Investors Co..
03/03 COVANCE INC. : Covance To Present At The Raymond James 35th Annual Institutional..
02/27 COVANCE INC. : COVANCE INC - 10-K - Management's Discussion and Analysis of Fina..
02/24 COVANCE INC. : Covance To Present At The Citi 2014 Global Healthcare Conference
02/24 COVANCE INC. : COVANCE INC FILES (8-K) Disclosing Change in Directors or Princip..
02/12 COVANCE INC. : Covance Reports Fourth Quarter Net Revenue Of $623 Million, Pro F..
02/11 COVANCE INC. : Covance to Present at the Leerink Swann 2014 Global Healthcare Co..
02/04 COVANCE INC. : COVANCE INC FILES (8-K) Disclosing Results of Operations and Fina..
02/04 COVANCE INC. : Covance Reports Fourth Quarter Net Revenue Of $623 Million, Pro F..
01/23 COVANCE INC. : Covance To Open Nutritional Chemistry And Food Safety Site In Har..
01/21 COVANCE INC. : Covance Appoints Dr. Barry J. Goldstein to Lead Expanded Cardiova..
01/12 COVANCE INC. : Covance to Present at the 32nd Annual J. P. Morgan Healthcare Con..
01/07 COVANCE INC. : Covance shares rise following analyst upgrade
01/07 COVANCE INC. : Covance shares rise following analyst upgrade
01/02 COVANCE INC. : Invites You to Join the Webcast of Its Fourth Quarter 2013 Financ..
2013 COVANCE INC. : Supply of Tab. SelokenXL 25 mg Tab.
2013 COVANCE INC. : Covance Board Authorizes $100M Stock Buyback
2013 COVANCE INC. : Covance Board Authorizes $100 Million Stock Buyback
2013 COVANCE INC. : Court Orders, Stock Price Movements, FDA Approvals and Strategic ..
2013 COVANCE INC. : Covance To Present At The Credit Suisse Healthcare Conference
2013 Covance To Present At The Credit Suisse Healthcare Conference
2013 COVANCE INC. : COVANCE INC FILES (8-K) Disclosing Creation of a Direct Financial..
2013 COVANCE INC FILES (8-K) Disclosing Creation of a Direct Financial Obligation ..
2013 COVANCE INC. : Covance NeoGenomics Enter Strategic Alliance for Anatomic Patholo..
2013 Covance NeoGenomics Enter Strategic Alliance for Anatomic Pathology and Speci..
2013 COVANCE INC. : Covance Central Laboratories and NeoGenomics Enter into Exclusive..
2013DJCAXTON ASSOCIATES LP 3Q 13F : Largest Eliminations
2013DJCAXTON ASSOCIATES LP 3Q 13F : Holdings As Of Sep 30 -2-
2013DJCAXTON ASSOCIATES LP 3Q 13F : Holdings As Of Sep 30
2013 COVANCE INC. : Covance To Present At The Credit Suisse Healthcare Conference
2013 COVANCE INC. : Covance and Pathoquest Establish Exclusive Collaboration to Provi..
2013 COVANCE INC. : Covance Reports Third Quarter Net Revenue Of $607 Million, Pro Fo..
2013COVANCE INC. : quaterly earnings release
2013 COVANCE INC. : Extended Partnership, Quarterly Reports, and Note Purchase Agreem..
2013 COVANCE INC. : Covance Announces $250 Million Long-Term Private Placement Debt F..
2013 COVANCE INC. : Covance Launches External Laboratory Management Services for Spec..
2013 COVANCE INC. : Invites You to Join the Webcast of Its Third Quarter 2013 Financi..
2013 COVANCE INC. : Covance To Present At The Morgan Stanley Global Healthcare Confer..
2013 COVANCE INC. : Covance and the Indiana Clinical and Translational Sciences Insti..
2013 COVANCE INC. : Covance Listed in Diversity Employers’ Top 100 for Fourth Consecu..
2013 COVANCE INC. : Covance Launches Managed Markets Services
2013 COVANCE INC. : Wall Street Fundamentals Releases New In-Depth Stock Reports on C..
2013DJU.S. HOT STOCK FUTURES : Hot stocks to watch
2013 COVANCE INC. : Invites You to Join the Webcast of Its Second Quarter 2013 Financ..
2013DJU.S. HOT STOCK FUTURES : Hot stocks to watch
2013 COVANCE INC. : Covance Reports Second Quarter Net Revenue of $592 Million, Pro F..
2013 COVANCE INC. : Covance Central Laboratory Services Again Ranks #1 in Global Inve..
2013 COVANCE INC. : Covance and NAFC Provide More Than 800 Patients in New Orleans wi..
2013 COVANCE INC. : Invites You to Join the Webcast of Its Second Quarter 2013 Financ..
2013 COVANCE INC. : Nutraceutical Business and Technology Awards Recognize Covance & ..
2013 COVANCE INC. : Covance To Present At The William Blair 33rd Annual Growth Stock ..
2013 COVANCE INC. : Covance To Present At The Goldman Sachs 34th Annual Global Health..
2013 COVANCE INC. : Covance To Present At The Bank Of America Merrill Lynch 2013 Heal..
2013 COVANCE INC. : Covance To Present At The R. W. Baird 2013 Growth Stock Conferenc..
2013 COVANCE INC. : Invites You to Join the Webcast of Its First Quarter 2013 Financi..
2013 COVANCE INC. : Covance Reports First Quarter Net Revenue Growth Of 9.3% To $580 ..
2013 COVANCE INC. : Covance Expands Singapore Central Laboratory by 50 Percent to Mee..
2013 COVANCE INC. : Invites You to Join the Webcast of Its First Quarter 2013 Financi..
2013 COVANCE INC. : Laboratory Recognized For Meeting Highest International Quality S..
2013 COVANCE INC. : Covance and M2Gen® Enter into Alliance to Promote Faster Patient ..
2013 COVANCE INC. : Covance To Present At The Citi 2013 Global Healthcare Conference
2013 COVANCE INC. : Covance To Present At The Leerink Swann Global Healthcare Confere..
2013 COVANCE INC. : Invites You to Join the Webcast of Its Fourth Quarter 2012 Financ..
2013 COVANCE INC. : Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Mill..
2013 COVANCE INC. : Covance and the Royal Liverpool and Broadgreen University Hospita..
2013 COVANCE INC. : Covance and the Royal Liverpool and Broadgreen University Hospita..
2013 COVANCE INC. : Covance To Present At The 31st Annual J. P. Morgan Healthcare Con..
2013 COVANCE INC. : Invites You to Join the Webcast of Its Fourth Quarter 2012 Financ..
2012 COVANCE INC. : Covance Receives SFDA GLP Certification for Its Early Development..
2012 COVANCE INC. : Covance Earns CEO Cancer Gold Standard Employer Accreditation
2012 COVANCE INC. : Covance To Present At The Lazard Capital Markets 9th Annual Healt..
2012 COVANCE INC. : Invites You to Join the Webcast of Its Third Quarter 2012 Financi..
1  2  3  4Next
Advertisement
Chart
Duration : Period :
Covance Inc. Technical Analysis Chart | CVD | US2228161004 | 4-Traders
Income Statement Evolution
Covance Inc. : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF